334. Implementation of FilmArray Meningitis/Encephalitis Panel at a Tertiary Medical Center
Session: Poster Abstract Session: CNS Infections
Thursday, October 4, 2018
Room: S Poster Hall

Background: A rapid and accurate meningitis/encephalitis diagnostic test can have a significant clinical impact and improve utilization of antimicrobial agents. The FilmArray Meningitis/Encephalitis Panel, a multiplex PCR meningitis/encephalitis panel (MEP) (bioMérieux, Marcy l’Etoile, France) requires only 200 μL of cerebral spinal fluid (CSF) and takes less than one hour to simultaneously detect 14 pathogens. The objective of the study was to evaluate the outcome of MEP at our medical center.

Methods: Retrospective review of 433 patients with a MEP performed from 4/2017 to 3/2018. Demographics characteristics, signs and symptoms, immune status, laboratory and radiology results and antibiotic use were collected.

Results: 29 unique patients with positive CSF samples (Table 1). The mean age was 41 years old with 55 % female predominance. The most common presentations were headache (65%) and fever (38 %). Patients with H. influenzae and Group B Strep meningitis had positive blood culture (CX) but negative CSF CX. Both the CSF and the blood CX were negative for the patient with L. monocytogenes. MEP identified six Cryptococcus sp. with concurrent positive CSF CX and Cryptococcus antigen. However, 3 patients had CSF Cryptococcus CX positive but MEP was negative. Only one of six patients with HHV-6 received treatment. 

Table 1. Pathogen identified with FilmArray ME Panel

Pathogen Detected

# positive MEP

Human herpes virus-6 (HHV6)*


Cryptococcus gattii/neoformans*




Human simplex virus (HSV)-2




Varicella zoster




Streptococcus agalactiae


Haemophilus influenzae


Escherichia coli K1


Listeria Monocytogenes


Streptococcus Pneumoniae


Human parechovirus


Neisseria Meningitis


*One patient with Cryptococcus and HHV-6 co-infection

Multiple Pathogen Detected

# of Patients   

Epstein Barr Virus  + HHV 6


Cryptococcus + HHV 6



Conclusion: The FilmArray MEP can rapidly diagnose ME infections, help to target therapy and allow for discontinuation of unnecessary empiric agents. Paired cultures are needed for drug susceptibility tests and in patients suspected of Cryptococcus meningitis due to false negative MEP results. Majority of patients with HHV-6 did not receive treatment and attributed the positive result due to possibly chromosomal integration of HHV6.


Sisham Ingnam, MD1, Philip Goldstein, MD1, Lynn Wardlow, PharmD, MBA, BCPS-AQ ID2, Joan-Miquel Balada-Llasat, Pharm D, PhD3, Rodrigo Hasbun, MD, MPH4 and Shu-Hua Wang, MD, MPH, PharmD1, (1)Division of Infectious Disease, The Ohio State University Wexner Medical Center, Columbus, OH, (2)Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, (3)Clinical Microbiolgy, The Ohio State University, Columbus, OH, (4)Division of Infectious Diseases, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX


S. Ingnam, None

P. Goldstein, None

L. Wardlow, None

J. M. Balada-Llasat, None

R. Hasbun, Biofire: Speaker's Bureau , Speaker honorarium . Biomeriaux: Consultant , Consulting fee .

S. H. Wang, None

See more of: CNS Infections
See more of: Poster Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.